TrialDiabetes, obesity & metabolism2026

Efficacy and Safety of Intensifying Once-Weekly Insulin Icodec Treatment With Once-Weekly Semaglutide in Adults With Type 2 Diabetes: A Single-Arm, Open-Label, Treat-to-Target, Phase 3b Trial (ONWARDS 8).

Krzysztof Strojek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.